Every Milliliter Matters: Reclaiming Precision in High-Cost Specialty Drug Governance
In modern healthcare finance, specialty pharmaceuticals—particularly Part B injectable biologics across oncology, rheumatology, ophthalmology, and rare disease therapies—represent the fastest-growing
